BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16044175)

  • 1. Relationships between human serum resistin, inflammatory markers and insulin resistance.
    Bo S; Gambino R; Pagani A; Guidi S; Gentile L; Cassader M; Pagano GF
    Int J Obes (Lond); 2005 Nov; 29(11):1315-20. PubMed ID: 16044175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters.
    Chen CC; Li TC; Li CI; Liu CS; Wang HJ; Lin CC
    Metabolism; 2005 Apr; 54(4):471-5. PubMed ID: 15798953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella NA
    Scand J Clin Lab Invest; 2007; 67(2):215-25. PubMed ID: 17366001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does C-reactive protein identify a subclinical metabolic disease in healthy subjects?
    Bo S; Gambino R; Uberti B; Mangiameli MP; Colosso G; Repetti E; Gentile L; Cassader M; Pagano GF
    Eur J Clin Invest; 2005 Apr; 35(4):265-70. PubMed ID: 15816996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance.
    Janowska J; Zahorska-Markiewicz B; Olszanecka-Glinianowicz M
    Metabolism; 2006 Nov; 55(11):1495-9. PubMed ID: 17046552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women.
    De Pergola G; Ciampolillo A; Paolotti S; Trerotoli P; Giorgino R
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):265-9. PubMed ID: 17547687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease.
    Stejskal D; Adamovská S; Bartek J; Juráková R; Prosková J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):63-9. PubMed ID: 15034607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistin concentrations before and after weight loss in obese children.
    Reinehr T; Roth CL; Menke T; Andler W
    Int J Obes (Lond); 2006 Feb; 30(2):297-301. PubMed ID: 16189500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating visfatin level is correlated with inflammation, but not with insulin resistance.
    Oki K; Yamane K; Kamei N; Nojima H; Kohno N
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in serum resistin during weight loss in overweight subjects is related to lipid metabolism.
    Koebnick C; Wagner K; Garcia AL; Gruendel S; Lahmann PH; Weickert MO; Möhlig M; Harsch IA; Einig C; Speth M; Katz N; Trippo U; Zunft HJ
    Int J Obes (Lond); 2006 Jul; 30(7):1097-103. PubMed ID: 16477272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of adiponectin, resistin and high sensitive CRP level with the metabolic syndrome in childhood and adolescence.
    Cizmecioglu FM; Etiler N; Ergen A; Gormus U; Keser A; Hekim N; Hamzaoglu O; Hatun S
    Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):622-7. PubMed ID: 19235133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity.
    Hasegawa G; Ohta M; Ichida Y; Obayashi H; Shigeta M; Yamasaki M; Fukui M; Yoshikawa T; Nakamura N
    Acta Diabetol; 2005 Jun; 42(2):104-9. PubMed ID: 15944845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between serum resistin level and adiposity in obese individuals.
    Azuma K; Katsukawa F; Oguchi S; Murata M; Yamazaki H; Shimada A; Saruta T
    Obes Res; 2003 Aug; 11(8):997-1001. PubMed ID: 12917505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
    De Pergola G; Pannacciulli N; Coviello M; Scarangella A; Di Roma P; Caringella M; Venneri MT; Quaranta M; Giorgino R
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):227-32. PubMed ID: 17400434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
    Kim CS; Park HS; Kawada T; Kim JH; Lim D; Hubbard NE; Kwon BS; Erickson KL; Yu R
    Int J Obes (Lond); 2006 Sep; 30(9):1347-55. PubMed ID: 16534530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between insulin resistance and serum levels of adiponectin and resistin with childhood obesity.
    Zou CC; Liang L; Hong F
    Indian Pediatr; 2007 Apr; 44(4):275-9. PubMed ID: 17468522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reduced resistin levels in patients with type 2 diabetes mellitus].
    Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.
    Vogeser M; König D; Frey I; Predel HG; Parhofer KG; Berg A
    Clin Biochem; 2007 Sep; 40(13-14):964-8. PubMed ID: 17583689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.